2024-514581-39-00CompletedPhase 1/2
Therapeutic vaccination: Phase I / II clinical study on patients randomized blinded to the experimental vaccine or placebo regimen. we want to evaluate the safety and the immunogenicity of a vaccine that includes a first administration of the ChAdOx1.tHIVconsvX product and a second one with MVA.tHIVconsvX in HIV-1 positive adults treated early and able to control the infection for a long time.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Aug 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 12 Jul 2024
- Start date
- 8 Nov 2023
- Lead sponsor
- Ospedale San Raffaele S.r.l.
- Diseases
- HIV
- EU CT number
- 2024-514581-39-00
- EudraCT number
- 2019-003102-26
What you commit to
- Study type: Interventional · Phase 1/2
- Participants enrolled: 33
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ospedale San Raffaele S.r.l. | Milan | Italy | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.